Stocks moved sharply across multiple sectors in midday trading, with chipmakers rebounding after a prior-session sell-off tied to investor concerns about artificial intelligence-related trade. At the same time, several company-specific developments drove outsized gains and losses, including a debt financing plan at Axon Enterprise, a fresh outlook update from Revvity, a disappointing quarter at Dave & Buster’s, and a halted acquisition effort at Enova International.
Key takeaways
- Skyworks Solutions rose 10% and Qorvo gained 7% as investors bought back chip exposure following the earlier sell-off.
- Axon Enterprise fell 9% after announcing the sale of $1 billion in convertible senior notes.
- Revvity jumped 7% to a new 52-week high after management offered detail on the remainder of its year and highlighted backlog and shipping timing.
- Dave & Buster’s plunged 17% on weaker-than-expected second-quarter results across revenue and profitability metrics.
- Enova International dropped more than 25% after withdrawing regulatory applications tied to its proposed acquisition of Grasshopper Bancorp.
What drove the move
In semiconductors, Skyworks Solutions and Qorvo snapped higher as the market reassessed recent risk. According to the report, both stocks had fallen in the prior session amid safety concerns surrounding artificial trade, and shares then rebounded midday.
Within defense and public safety, Axon Enterprise weighed on the news. Shares fell 9% after the Taser maker said it would sell $1 billion in convertible senior notes. Investors typically scrutinize convertibles for dilution risk and financing cost assumptions, particularly when issuance occurs alongside broader funding and capital-return decisions.
Life sciences tools were a bright spot. Revvity shares advanced 7% to reach a fresh 52-week high after the company discussed its outlook for the rest of the year at a Baird healthcare conference. The report said Revvity ended the second quarter with a strong backlog, and that orders not completed in the quarter are expected to ship in the third and fourth quarters—an important timing factor for revenue recognition and near-term execution confidence.
Earnings, guidance, and deal news reshape individual stocks
Consumer leisure saw one of the steepest declines. Dave & Buster’s Entertainment shares fell 17% after results undershot investor expectations. According to the report, quarterly revenue was $544.1 million versus a $556.8 million FactSet consensus estimate. Adjusted EBITDA came in at $98.9 million, below the $120.4 million expectation. The company also posted an unexpected adjusted loss of 27 cents per share, compared with an anticipated profit of 18 cents per share, as measured by analysts polled by FactSet.
In financial services, Enova International tumbled more than 25% after it said it is withdrawing its regulatory applications for the proposed acquisition of Grasshopper Bancorp. The report also noted that Enova reaffirmed its third-quarter and full-year guidance and said it plans to accelerate share repurchases, suggesting management is attempting to rebalance capital priorities even as the deal pathway was paused or ended.
Healthcare services and software also saw major moves. Alignment Healthcare shares dropped 18% as leadership pointed to headwinds in its institutional acute business and said the length of stays rose in skilled nursing, according to StreetAccount. While the company said it does not expect those trends to persist into 2027, it indicated it will not change its 2026 guidance for now, leaving investors focused on whether near-term pressures can be contained.
In logistics and procurement, Sysco slipped 3% following an equity offering. The report said the wholesale distributor to restaurants, hospitals and schools announced a common stock offering of 12.3 million shares priced at $81 apiece. Such offerings can affect valuation through dilution, even when companies pursue financing to support operational needs and capital allocation.
By contrast, Waystar rose more than 8%. Reuters, cited in the report, said the healthcare software provider is exploring a potential sale that could take the company private. The stock has reportedly declined 17% in 2026, which may have left it sensitive to credible takeover interest, given the potential for a change in ownership structure and valuation framework. Waystar’s software supports hospital and physician payments management.
Crypto-linked stocks slide ahead of regulatory vote
Crypto-linked equities declined as Bitcoin and related stock exposure weakened ahead of a Senate vote on the Clarity Act, legislation intended to establish a regulatory framework for the crypto market. According to the report, Coinbase shares dropped more than 5% and crypto miner Riot Platforms fell 4%. Strategy, which the report described as a Bitcoin treasury play, slid 3%.
What to watch next
Investors are likely to stay focused on follow-through from the rebound in chip stocks and on the durability of demand signals cited by Revvity. For companies facing capital and deal-related scrutiny—such as Axon Enterprise with its convertible issuance, Sysco with its equity offering, and Enova after withdrawing acquisition-related filings—next steps and any subsequent guidance updates could drive further volatility. Ahead of the broader market, attention will also remain on the Senate’s crypto regulatory vote and how it shapes expectations for the sector.
